$10.75 +0.36 (3.47%) Advaxis Inc - NASDAQ

Sep. 30, 2016 | 02:50 PM
Last Trade: 10.75
Trade Time: Sep 30 02:50 PM Eastern Daylight Time
Change: +0.36 (3.47%)
Prev Close: 10.39
Open: 10.50
Bid: 10.74
Ask: 10.76
  1. Why Shares Of Advaxis Moved Higher On Tuesday

    Benzinga | Jan. 5, 2016 | 13:51PM EST
  2. Benzinga's Volume Movers

    Benzinga | Dec. 16, 2015 | 10:24AM EST
  3. ADVAXIS

    IBD | Oct. 6, 2015 | 18:35PM EST
  4. First Human Patient Treated in Phase 1b Study of Advaxis's ADXS-HER2 in HER2 Expressing Solid Tumors

    Benzinga | Sep. 28, 2015 | 09:05AM EST
  5. Phase 2 Study of Advaxis's Axalimogene Filolisbac (ADXS-HPV) in Cervical Cancer to be Presented at 2015 AGOS Annual Meeting

    Benzinga | Aug. 31, 2015 | 09:05AM EST
  6. Advaxis Announces Licensing Agreement With Knight Therapeutics and Raises $25 Million Through ...

    GuruFocus | Aug. 27, 2015 | 00:02AM EST
  7. Advaxis Offers '15 Half-Year Review, Outlook

    Benzinga | Jun. 25, 2015 | 07:31AM EST
  8. Advaxis Submits Special Protocol Assessment Request to FDA for ADXS-HPV Phase 3 Clinical Trial in Cervical Cancer

    Benzinga | Jun. 15, 2015 | 09:05AM EST
  9. US Stock Futures Edge Lower; Sears Q1 Loss Narrows

    Benzinga | Jun. 8, 2015 | 07:45AM EST
  10. Advaxis's Cancer Immunotherapy Delays Progression of HER2+ Canine Osteosarcoma

    Benzinga | Jun. 8, 2015 | 07:32AM EST
  11. Benzinga's Top Initiations

    Benzinga | May. 15, 2015 | 09:47AM EST
  12. Janney Capital Initiates Advaxis At Buy

    Benzinga | May. 15, 2015 | 08:15AM EST
  13. Aratana Therapeutics Comments on ADXS31-164 (AT-014) Study Data Presented During Poster Session at the American Association for Cancer Research (AACR) Annual Meeting 2015

    Benzinga | Apr. 27, 2015 | 09:03AM EST
  14. Advaxis Presents Lm-LLO Cancer Immunotherapy Data at the 2015 American Association for Cancer Research Meeting

    Benzinga | Apr. 21, 2015 | 13:11PM EST
  15. Morning Market Gainers

    Benzinga | Feb. 11, 2015 | 09:48AM EST
Trading Center